News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires2d agobullish
B. Riley Adjusts Price Target on Novavax to $16 From $18, Keeps Buy Rating24/7 Wall St.11d agobullish
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge HigherSimply Wall St.54d agobullish
Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act?24/7 Wall St.68d agobullish
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?Stocktwits72d agobullish
NVAX Stock Climbs As Partnership Model Keeps COVID Vaccine Cash Flow OpenBarchart79d agobullish
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer BreakthroughBarrons.com81d agobullish
BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.Simply Wall St.92d agobullish
Novavax (NVAX) Is Up 8.6% After Beating Q2 Estimates And Expanding Big-Pharma Partnerships - What's ChangedInvestorsHub94d agobullish
Novavax tops forecasts and raises revenue outlook as Sanofi collaboration progresses24/7 Wall St.145d agobullish
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?Simply Wall St.181d agobullish
Novavax (NVAX) Is Up 25.9% After Pfizer Matrix-M Deal And Q1 Beat On Expectations - What's Changed24/7 Wall St.181d agobullish
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?